NCT06404502 Feasibility and Acceptability of PRISMA for Prisoners in Switzerland
| NCT ID | NCT06404502 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Zurich |
| Condition | Psychological Distress |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2023-12-08 |
| Primary Completion | 2024-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2023-12-08 with a primary completion date of 2024-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In response to the significant mental health challenges faced by pretrial detainees, the Swiss Federal Justice Department has initiated a model trial in pretrial detention centres in Zurich and Bern. This model trial, named in German as a "Modellversuch," is designed to enhance detainees' wellbeing and evaluates various interventions through a randomized controlled trial. The "Prison Stress Management" (PRISMA) programme, a key intervention derived from the WHO's cognitive-behavioral therapy strategies, seeks to address the lack of mental health support within jails. The goal of this pilot RCT is to evaluate the feasibility and acceptability of PRISMA for inmates inform a full-scale, definitive randomized controlled trial.
Eligibility Criteria
Inclusion Criteria: * Entering pretrial detention inmate in any of the 11 pretrial detention facilities in the Cantons of Zurich and Bern * aged ≥ 18 years Exclusion Criteria: * Not fluently speaking any of the nine languages in which PRISMA is offered: German, Albanian, Arabic, English, French, Italian, Romanian, Serbian/ Croatian, Spanish * Acute suicidality * Not interested in PRISMA and its randomized evaluation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06404502 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06404502 currently recruiting?
Yes, NCT06404502 is actively recruiting participants. Contact the research team at naser.morina@usz.ch for enrollment information.
Where is the NCT06404502 trial being conducted?
This trial is being conducted at Zurich, Switzerland.
Who is sponsoring the NCT06404502 clinical trial?
NCT06404502 is sponsored by University of Zurich. The trial plans to enroll 40 participants.